Stocktoria
Fuse Medical, Inc. FZMD
OTC · stock · Wholesale-Medical, Dental & Hospital Equipment & Supplies · website · IPO 1980-10-30
Fuse Medical, Inc. financials (annual, from 10-K)
Bars are annual figures from 2013 to 2022; red bars are negative (a loss or cash outflow).
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18.6M | $20.4M | $21.4M | $22.9M | $26.3M | $26.4M | $25.7M | $1.7M | $941,086 | $1.1M |
| Gross profit | $11.5M | $11.9M | $12.7M | $11.1M | $13.0M | $11.8M | $14.4M | $1.0M | $455,702 | $855,807 |
| SG&A expense | $6.5M | $7.0M | $6.5M | $8.5M | $8.5M | $5.3M | $4.2M | — | — | — |
| Operating income | -$815,072 | -$2.2M | -$1.0M | -$4.3M | -$2.0M | $858,857 | $3.2M | -$794,435 | -$1.3M | $436,055 |
| Interest expense | $171,294 | $78,230 | $94,953 | $121,633 | $133,944 | $161,669 | $146,921 | $6,712 | $71,612 | $669 |
| Income tax | $23,655 | $17,723 | $18,993 | $781,085 | -$386,784 | $40,818 | $51,627 | $0 | — | — |
| Net income | $3.1M | -$1.6M | -$1.4M | -$3.3M | $4.0M | $699,678 | $3.0M | -$801,547 | -$1.4M | $435,386 |
| EPS (diluted) | $0.04 | $-0.02 | $-0.02 | $-0.05 | $0.05 | $0.04 | $0.33 | — | — | — |
| Operating cash flow | $34,799 | -$1.8M | $236,654 | -$4,739 | $2.5M | $1.6M | $2.8M | -$375,140 | -$1.2M | $319,618 |
| Free cash flow | — | — | $215,897 | -$20,057 | $2.4M | $1.6M | — | -$383,448 | -$1.2M | $317,855 |
| Cash & equivalents | $147,854 | $553,190 | $1.2M | $1.1M | $844,314 | $804,715 | $778,447 | $263,625 | $67,555 | $233,081 |
| Inventory | $9.5M | $8.7M | $7.0M | $7.9M | $11.1M | $10.6M | $11.4M | $81,209 | $131,382 | — |
| Total assets | $19.8M | $18.3M | $17.4M | $18.4M | $22.2M | $19.2M | $19.6M | $435,005 | $545,873 | $11,501 |
| Total liabilities | $20.1M | $21.7M | $19.5M | $19.6M | $20.7M | $27.2M | $9.0M | $430,048 | $347,369 | $50,346 |
| Shareholders' equity | -$310,854 | -$3.4M | -$2.1M | -$1.2M | $1.5M | -$8.0M | $10.6M | $8.0M | $198,504 | $270,715 |
Growth · year-over-year · Revenue CAGR 37.5%
| Metric | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -8.7% | -4.6% | -6.6% | -13.1% | -0.2% | +2.9% | +1430.9% | +78.2% | -11.2% | — |
| Net income growth | — | — | — | -183.8% | +465.6% | -76.8% | — | — | -422.7% | — |
| EPS growth | — | — | — | -200.0% | +25.0% | -87.9% | — | — | — | — |
| Free cash flow growth | — | — | — | -100.8% | +53.9% | — | — | — | -486.9% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: SEC EDGAR filings · CIK 0000319016 · US · as of 2022-12-31. facts plus Stocktoria's own computed scores — not investment advice.